Certolizumab for repeated embryo transfer pregnancy failure
Treatments studied
Part of Immune system & allergy, Women’s health & pregnancy clinical trials.
This Phase 3 study tests certolizumab to help people with repeated embryo transfer failures achieve a clinical pregnancy. It may be an option if your infertility has no known cause and you meet the other study checks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 18 and 40 years old
- You have infertility with no clear cause, or the cause is male or blocked fallopian tubes (tubal factor)
- You have had repeated embryo transfers (at least two or more transfers of 3 good-quality embryos) without a clinical pregnancy
- You have French health coverage (including AME, if applicable) and can sign consent
- You do not have specific medical causes of repeated failure, like certain immune or infection-related problems
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at immune-related blood patterns and other measurements to better understand why some women have repeated pregnancy loss or repeated IVF implantation failure. If you qualify, your answers and test results may help researchers identify biomarkers that could guide future care.
This study looks at whether immune system or microbiome changes in the uterus are linked to repeated IVF failure or recurrent miscarriage. The goal is to better understand why some women struggle to get pregnant or stay pregnant.
This trial tests whether a drug called thymosin-α1 can help women who have had two or more failed embryo transfers with genetically normal embryos. It aims to improve the chances of successful implantation.
This study tests whether checking the timing of the uterine lining (endometrium) before transferring an embryo can help women who have had multiple failed embryo transfers. It aims to improve the chance of a successful pregnancy for women under 35 with no known cause for their infertility.
This trial tests whether acupuncture can improve the success of frozen embryo transfer in women who have had at least two failed attempts with good embryos. It may help if you're planning another frozen embryo transfer soon.
This trial tests whether a traditional Chinese medicine pill called Zishen Yutai can help with repeated implantation failure—when embryos fail to implant during in vitro fertilization (IVF). You would take this pill before a frozen embryo transfer to see if it improves your chances of pregnancy.
Hear when a new Recurrent Unexplained Implantation Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.